---
figid: PMC3491089__nihms405350f4
figlink: /pmc/articles/PMC3491089/figure/F4/
number: F4
caption: A schematic representation which shows possible mechanisms of action by δ-
  and γ-tocopherol in multiple signaling pathways involved in mammary carcinogenesis.
  Induction of PPARγ by δ- and γ-tocopherol may increase PTEN and p21 and reduce ERα
  and cyclin D1 resulting in the decrease of inflammation and cell proliferation.
  The cell cycle (p53 and p21) may be regulated by δ- and γ-tocopherol. Tumor suppressor
  p53 is able to positively regulate PTEN, p21 and BAX, while inhibiting Bcl2 and
  cyclin D, which increases apoptosis and reduces cell cycle progression. PPARγ and
  p53 increase the levels of PTEN, and as a result inhibit the Akt cell survival pathway.
  δ- And γ-tocopherols reduce c-Myc and PCNA which consequently decrease cell progression
  and proliferation. Pro-apoptotic proteins BAX, c-Casp9, c-Casp3 and c-PARP are increased
  while anti-apoptotic proteins XIAP and Bcl2 are decreased by δ- and γ-tocopherol.
  In summary, δ- and γ-tocopherol may activate PPARγ, PTEN, p53, the apoptotic pathway
  and Nrf2 and decrease ERα, p-Akt, cyclin D1 and PCNA to inhibit cell cycle progression
  and cell growth resulting in the inhibition of mammary tumorigenesis.
pmcid: PMC3491089
papertitle: Dietary administration of δ- and γ-tocopherol inhibits tumorigenesis in
  the animal model of estrogen-receptor positive, but not HER-2 breast cancer.
reftext: Amanda K. Smolarek, et al. Cancer Prev Res (Phila). ;5(11):1310-1320.
pmc_ranked_result_index: '11526'
pathway_score: 0.9627883
filename: nihms405350f4.jpg
figtitle: Schematic representation which shows possible mechanisms of action by D-
  and Gamma-tocopherol in multiple signaling pathways involved in mammary carcinogenesis
year: ''
organisms: Homo sapiens
ndex: 8602e3eb-ded8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3491089__nihms405350f4.html
  '@type': Dataset
  description: A schematic representation which shows possible mechanisms of action
    by δ- and γ-tocopherol in multiple signaling pathways involved in mammary carcinogenesis.
    Induction of PPARγ by δ- and γ-tocopherol may increase PTEN and p21 and reduce
    ERα and cyclin D1 resulting in the decrease of inflammation and cell proliferation.
    The cell cycle (p53 and p21) may be regulated by δ- and γ-tocopherol. Tumor suppressor
    p53 is able to positively regulate PTEN, p21 and BAX, while inhibiting Bcl2 and
    cyclin D, which increases apoptosis and reduces cell cycle progression. PPARγ
    and p53 increase the levels of PTEN, and as a result inhibit the Akt cell survival
    pathway. δ- And γ-tocopherols reduce c-Myc and PCNA which consequently decrease
    cell progression and proliferation. Pro-apoptotic proteins BAX, c-Casp9, c-Casp3
    and c-PARP are increased while anti-apoptotic proteins XIAP and Bcl2 are decreased
    by δ- and γ-tocopherol. In summary, δ- and γ-tocopherol may activate PPARγ, PTEN,
    p53, the apoptotic pathway and Nrf2 and decrease ERα, p-Akt, cyclin D1 and PCNA
    to inhibit cell cycle progression and cell growth resulting in the inhibition
    of mammary tumorigenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MYC
  - CDK4
  - PARP10
  - PCNA
  - PARP9
  - PARP4
  - PIK3R6
  - PIK3CG
  - PARP1
  - PARP2
  - PARP3
  - PARP12
  - CDK6
  - CASP9
  - AKT3
  - AKT1
  - ESR1
  - CASP3
  - BCL2
  - PIK3CB
  - PIK3CD
  - PRKCA
  - TNKS2
  - PARP11
  - APAF1
  - PARP15
  - PARP8
  - AKT2
  - CCND1
  - BAX
  - PIK3CA
  - TNKS
  - PIK3R5
  - PTEN
  - PIK3R4
  - KEAP1
  - XIAP
  - PARP6
  - PARP14
  - TP53
  - TIPARP
  - PIK3R3
  - PARP16
  - Cancer
genes:
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PCNA
  symbol: PCNA
  source: hgnc_symbol
  hgnc_symbol: PCNA
  entrez: '5111'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: C-Casp9
  symbol: CASP9
  source: hgnc_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: p-Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: p-Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERa
  symbol: ER-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: ESR1
  entrez: '2099'
- word: C-Casp3
  symbol: CASP3
  source: hgnc_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: BCL2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PKCa
  symbol: PKCA
  source: hgnc_prev_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: Apaf-1
  symbol: APAF-1
  source: hgnc_alias_symbol
  hgnc_symbol: APAF1
  entrez: '317'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: p-Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: BAX
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: KEAP1
  symbol: KEAP1
  source: hgnc_symbol
  hgnc_symbol: KEAP1
  entrez: '9817'
- word: XIAP
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: C-PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3491089__F4
redirect_from: /figures/PMC3491089__F4
figtype: Figure
---
